Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.94 USD | +0.39% | -17.21% | -40.29% |
Business Summary
Number of employees: 487
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Medicines
100.0
%
| 8 | 100.0 % | 86 | 100.0 % | +1,024.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 8 | 100.0 % | 86 | 100.0 % | +1,024.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Mike Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Laura Gault
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-30 |
Matt Lasmanis
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-31 |
Amy Schacterle
COO | Chief Operating Officer | - | 15-02-12 |
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Tammy J. Phinney
LAW | General Counsel | - | 20-07-31 |
Vanessa Procter
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Jim Frates
BRD | Director/Board Member | 56 | 14-04-30 |
Michael Cola
BRD | Director/Board Member | 64 | 14-09-10 |
Geno Germano
CHM | Chairman | 63 | 16-07-18 |
Director/Board Member | 67 | 19-01-22 | |
Director/Board Member | 62 | 19-01-22 | |
Jessica Federer
BRD | Director/Board Member | - | 23-03-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,109,720 | 52,558,950 ( 87.44 %) | 3,033 ( 0.005046 %) | 87.44 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.29% | 775M | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |
- Stock Market
- Equities
- SAGE Stock
- Company Sage Therapeutics, Inc.